Correlation Between Tarsus Pharmaceuticals and Genfit
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Genfit at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Genfit into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Genfit, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Genfit and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Genfit. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Genfit.
Diversification Opportunities for Tarsus Pharmaceuticals and Genfit
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Tarsus and Genfit is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Genfit in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genfit and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Genfit. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genfit has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Genfit go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Genfit
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 1.05 times more return on investment than Genfit. However, Tarsus Pharmaceuticals is 1.05 times more volatile than Genfit. It trades about 0.07 of its potential returns per unit of risk. Genfit is currently generating about 0.03 per unit of risk. If you would invest 1,674 in Tarsus Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 3,150 from holding Tarsus Pharmaceuticals or generate 188.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. Genfit
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| Genfit |
Tarsus Pharmaceuticals and Genfit Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and Genfit
The main advantage of trading using opposite Tarsus Pharmaceuticals and Genfit positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Genfit can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genfit will offset losses from the drop in Genfit's long position.| Tarsus Pharmaceuticals vs. Aldeyra | Tarsus Pharmaceuticals vs. Travere Therapeutics | Tarsus Pharmaceuticals vs. Eton Pharmaceuticals | Tarsus Pharmaceuticals vs. Connect Biopharma Holdings |
| Genfit vs. Lyra Therapeutics | Genfit vs. Hookipa Pharma | Genfit vs. Cingulate Warrants | Genfit vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |